Dr. Gary Feldman We are excited to announce that the Mirum clinical trial for Fragile X Syndrome (FXS) is now enrolling in Irvine, California, under the leadership of Dr. Gary Feldman, Principal Investigator. This study offers families the chance to explore an innovative treatment option and make informed decisions for their loved ones with FXS. […]


